Real-world Patterns of Genetic Testing in Urologic Malignancies: Guideline Recommendations Versus Clinical Practice
https://www.goldjournal.net/article/S0090-4295(26)00318-3/abstract
Of >125K eligible patients w/ cancer these had germline testing:
kidneycancer 9%
adrenalcancer 9%
UTUC 16%
bladdercancer 8%
prostatecancer 10%
100% of the above patients w/ urologiccancer met guideline eligibility for #genetictesting
Conclusion
Despite clear guideline recommendations, genetic testing remains underutilised across urologic cancers, with significant disparities by disease type, age, and race.
These results emphasize the importance of ongoing provider education, system-level support, and equity-focused strategies to enhance uptake of genetic testing in urologic oncology practice.
Lynch Syndrome Ireland 